Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report

INTRODUCTION: To date, there is no treatment with proven efficacy for cutaneous leukocytoclastic vasculitis (CLV). Several reports have suggested that CLV responds favorably to corticosteroids, colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs), azathioprine, and hydroxychloroquine (HCQ). To...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Kai-Jun, Yang, Pei-Dan, Xu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264360/
https://www.ncbi.nlm.nih.gov/pubmed/34248994
http://dx.doi.org/10.3389/fimmu.2021.695768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264360/
https://www.ncbi.nlm.nih.gov/pubmed/34248994
http://dx.doi.org/10.3389/fimmu.2021.695768

Ejemplares similares